Literature DB >> 20080041

Recent advances in processing and presentation of CD1 bound lipid antigens.

Mariolina Salio1, Jonathan D Silk, Vincenzo Cerundolo.   

Abstract

It is well established that different populations of alphabeta T lymphocytes can recognize not only peptides in the context of MHC class I and class II molecules, but also foreign and self-lipids in association with CD1 proteins, which share structural similarities with MHC class I molecules. CD1 molecules are comprised of five isoforms, known as group 1 (CD1a, b, c, e) and group 2 (CD1d) CD1, presenting lipid antigens to conventional T lymphocytes or innate-like T cells bearing an invariant T cell receptor (TCR) and known as invariant NKT (iNKT) cells. During the last couple of years, several papers have been published describing important aspects of the mechanisms controlling the processing and presentation of endogenous and exogenous CD1 lipid antigens, which will be the main focus of this review. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080041     DOI: 10.1016/j.coi.2009.12.008

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  27 in total

1.  Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.

Authors:  Lisa M Fox; Jennifer Miksanek; Nathan A May; Louise Scharf; Jennifer L Lockridge; Natacha Veerapen; Gurdyal S Besra; Erin J Adams; Amy W Hudson; Jenny E Gumperz
Journal:  Cancer Immun       Date:  2013-05-10

Review 2.  How dendritic cells shape atherosclerosis.

Authors:  Ekaterina K Koltsova; Klaus Ley
Journal:  Trends Immunol       Date:  2011-08-10       Impact factor: 16.687

3.  Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.

Authors:  Ramesh Chandra Halder; Cynthia Tran; Priti Prasad; Jing Wang; Dhiraj Nallapothula; Tatsuya Ishikawa; Meiying Wang; Dirk M Zajonc; Ram Raj Singh
Journal:  Eur J Immunol       Date:  2018-12-18       Impact factor: 5.532

4.  4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.

Authors:  Geoffrey D Wool; Veneracion G Cabana; John Lukens; Peter X Shaw; Christoph J Binder; Joseph L Witztum; Catherine A Reardon; Godfrey S Getz
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

5.  Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.

Authors:  Jennifer C Bailey; Abhirami K Iyer; Gourapura J Renukaradhya; Yinling Lin; Hoa Nguyen; Randy R Brutkiewicz
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

6.  Immunology: oiling the wheels of autoimmunity.

Authors:  Mitchell Kronenberg; Wendy L Havran
Journal:  Nature       Date:  2014-02-06       Impact factor: 49.962

Review 7.  Coevolution of T-cell receptors with MHC and non-MHC ligands.

Authors:  Caitlin D Castro; Adrienne M Luoma; Erin J Adams
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

8.  Human mucosal associated invariant T cells detect bacterially infected cells.

Authors:  Marielle C Gold; Stefania Cerri; Susan Smyk-Pearson; Meghan E Cansler; Todd M Vogt; Jacob Delepine; Ervina Winata; Gwendolyn M Swarbrick; Wei-Jen Chua; Yik Y L Yu; Olivier Lantz; Matthew S Cook; Megan D Null; David B Jacoby; Melanie J Harriff; Deborah A Lewinsohn; Ted H Hansen; David M Lewinsohn
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

Review 9.  Recognition of CD1d-restricted antigens by natural killer T cells.

Authors:  Jamie Rossjohn; Daniel G Pellicci; Onisha Patel; Laurent Gapin; Dale I Godfrey
Journal:  Nat Rev Immunol       Date:  2012-11-16       Impact factor: 53.106

10.  Dynamics of the antigen-binding grooves in CD1 proteins: reversible hydrophobic collapse in the lipid-free state.

Authors:  Diana Garzón; Claudio Anselmi; Peter J Bond; José D Faraldo-Gómez
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.